Five Below Inc vs Novo Nordisk A/S — how do they compare? Five Below Inc trades at $234.71 (market cap $12.95B), while Novo Nordisk A/S trades at $45.99 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 16.1× Five Below Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Five Below Inc pays none. Which is the better fit depends on your goals.
| FIVE | NVO | |
|---|---|---|
Market Cap | $12.95B | $207.85B |
Sector | Consumer Staples | Health |
52-Week High | $247.71 | $63.98 |
52-Week Low | $134.36 | $35.29 |
Enterprise Value | $13.84B | $222.55B |
Dividend Yield | — | 3.81% |
Trailing returns across standard periods
Latest headlines on both assets
Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics
Read more on FIVE →With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →